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Hemoglobin (Hb) E disease is the most common Hb variant in Southeast Asia. However, in India, it is prevalent in Eastern India and West Bengal but is 
relatively rare in rest of the country. Worldwide, patients with 
Hb E/β-thalassemia represent approx. 50% of those affected 
with severe beta-thalassemia. The highest frequencies are 
observed in India, Bangladesh, and throughout Southeast Asia, 
particularly in Thailand, Laos, and Cambodia. It has recently 
become the most common form of β-thalassemia identified by 
many newborn screening programs. There is a widely disparate 
range of clinical and hematological parameters in patients with 
Hb E/β-thalassemia. Its phenotypic variability, an emerging 
awareness that its phenotype may evolve overtime, and the 
limited understanding of its natural history combine to make the 
management of Hb E/β-thalassemia, particularly challenging.
Once a child has been diagnosed as thalassemia, he/she has 
to take lifelong treatment that can be availed by only 5–10% 
thalassemic children in India. For a chronic disease such as 
thalassemia, where cure is not attainable and treatment may 
be prolonged, quality of life (QOL) is likely to be an essential 
outcome. Children are usually unable to express their concerns; 
thus, the assessment of QOL is essential for the provision of 
proper care as it helps in identifying the impact of the disease and 
treatment from the child’s perspective. However, this aspect has 
not received due attention and priority from the relevant health-
care delivery system.
Research findings in this regard are also very limited. 
However, information in this aspect in our country, including 
West Bengal, is scarce, which has the highest prevalence of Hb 
E/β-thalassemia. A better understanding of the factors associated 
with QOL among these children is required for the development 
of more suitable clinical, counseling, and social support program 
to enhance treatment outcome, especially in terms of QOL. The 
aim of the study was to assess the QOL in Hb E/β-thalassemia 
children with special reference to iron overload.
MATERIALS AND METHODS
This was a cross-sectional study conducted between April 1, 
2016, and March 31, 2017, on 50 children attending thalassemia 
day care unit and outdoor departments of pediatric medicine and 
hematology of a tertiary care hospital of Eastern India. All the 
children who were 8–12 years old and diagnosed cases of Hb 
E-β-thalassemia were included in the study. Children who were 
non-Hb E-β-thalassemia or children with Hb E/β-thalassemia 
aged <8 years or >12 years or children with Hb E/β-thalassemia 
with other organ dysfunctions not related to thalassemia were 
excluded from the study.
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All subjects of the study population were studied in a 
methodical manner in a predesigned PedsQL 4.0 generic core 
scale [02]. A detailed history and clinical examination were done. 
Age and sex of the subjects were noted. The investigations done 
were serum ferritin and pre-transfused Hb level. Childhood 
psychopathology measurement schedule (CPMS) was also noted.
All the statistical analyses were done in SPSS software 
version 20.0. Difference between two mean values was tested by 
unpaired Student’s t-test, while analysis of variance was used to 
compare more than 2 values. Degree and direction of relationship 
between two variables was computed by Pearson’s correlation 
coefficient (r).
RESULTS
A total of 50 children, with Hb E/β-thalassemia, were interviewed 
children during the study period with the mean age of 
9.98±1.39 years and male and female ratio of 1.38:1. A total of 
58% of children were male and 42% were female (Table 1). We 
found that Muslim population was higher (54%) than the Hindu 
population and 28% of children had a history of consanguineous 
marriage of parents. It was observed that most of the subjects 
(66%) belonged to nuclear families and most of the children were 
residents of rural region (70%).
Most of the subjects (36%) belonged to the upper-
lower socioeconomic status (according to modified Prasad’s 
classification). Most of the children (58%) received blood 
transfusion last time when pre-transfusion Hb level was 
between 5 and 7 g/dl. The majority of subjects were receiving 
blood transfusion for the past 2–5 years (28%) and only 20% of 
population received blood transfusion more than 5 times in the 
past 1 year. A total of 58% of children were on oral chelation 
therapy and the majority of them got drugs from our hematology 
unit. Iron overload was determined by serum ferritin; although, 
ferritin level was lower when chelation therapy was continued.
It was found that mean score of QOL (total) was 63.51. 
The mean score of social domain was the highest score (66.10) 
among the mean scores in different QOL domains and was the 
worst in the school domain (60.70). Most of the study population 
has the CPMS score in the range of 18.4–21.2. The QOL score 
Table 1: Distribution of QOL scores
Variable Observations Minimum Maximum Mean SD
QOL (physical) 50 46.87 75.0 64.21 5.88
QOL (emotional) 50 50.00 75.00 63.40 5.19
QOL (social) 50 50.00 75.00 66.10 5.65
QOL (school) 50 50.00 70.00 60.70 5.98
QOL (total) 50 51.71 72.97 63.56 4.86
QOL: Quality of life
Table 2: QOL score and CPMS score in relation to pre-transfusion Hb, frequency of blood transfusion, and iron chelation
Variables Scores in various domains (mean±SD) p value
Frequency of blood transfusion QOL 2–5 times (40) >5 times (10)
Physical 64.58±6.20 62.71±4.28 0.37
Emotional 63.37±5.35 63.50±4.74 0.94
Social 65.87±5.76 67.00±5.37 0.578
School 60.75±6.15 60.50±5.50 0.90
Total QOL 63.67±5.04 62.83±4.20 0.62
CPMS 23.45±4.71 23.50±4.00 0.97
Iron chelation QOL YES (29) NO (21)
Physical 66.73±4.98 60.72±5.29 0.0002*
Emotional 65.69±3.94 60.23±5.11 <0.0001*
Social 67.58±5.11 64.04±5.83 0.02*
School 64.13±4.02 55.95±4.90 <0.0001*
Total QOL 65.85±3.60 60.27±4.56 <0.0001*
CPMS 22.65±4.83 24.57±3.94 0.142
Pre-transfusion Hb level (g/dl) QOL <5 (12) 5–7 (29) >7 (9)
Physical 61.82±4.13 64.34±6.26 66.60±5.99 –0.177
Emotional 62.08±3.96 63.64±5.32 64.44±6.34 –0.561
Social 65.00±4.76 65.53±6.13 68.00±5.37 –0.81
School 58.07±5.22 60.92±6.51 63.50±4.11 –0.09
Total QOL 60.60±3.22 63.62±5.15 66.01±5.14 –0.049*
CPMS 22.25±3.95 23.75±4.53 24.11±5.46 –0.568
QOL: Quality of life, CPMS: Childhood psychopathology measurement schedule, Hb: Hemoglobin
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was significantly better in males than in females and in Hindu 
population than in Muslims. There was no statistically significant 
difference in QOL score and CPMS score in urban or rural 
population, joint or nuclear family, and presence or absence of 
the history of consanguineous marriage in parents. We found that 
QOL was significantly better in upper-middle class population in 
total score along with physical and school functioning (Table 2).
The QOL score was significantly better when pre-transfusion 
Hb level was above 7 g/dl and in subjects receiving iron chelation 
therapy; however, no significant difference was seen in CPMS 
score. It was found that in the correlation matrix, independent 
variables were interrelated. Hence, to get true relation between 
independent and dependent variables, multiple linear regression 
analysis was done. QOL score was positively correlated with the 
pre-transfusion Hb level >7 g/dl and socioeconomic status and 
negatively correlated with the duration of blood transfusion and 
ferritin level.
DISCUSSION
In the present study, overall QOL score of these children 
was 63.50±4.86 which was in accordance to the studies 
done by El Dakhakhny et al. (64.8±13.8) [1] and 
Thavorncharoensap et al. (76.67±11.40) [2]. PedsQL™ 4.0 was 
used in the previous studies [3-5]. The social functioning score 
was 66.10±5.65 which was the highest among the different 
domains of QOL and the school domain was the worst. These 
results were also supported by Gharaibeh and Gharaibeh [6]. 
Saha et al. [7] observed that the school domain had significantly 
low score (49.42) in thalassemic children. We used CPMS score 
for the psychological assessment and it was also used previously 
by Shaligram et al. [8]. In the present study, CPMS score was 
23.46±4.54 and the total summary score was found to be a good 
score for psychological status.
In this study, the QOL score (total, school, social, and 
emotional health domain) was higher in male than in female 
population which contradicts the results of studies by Saha et al. 
and Borgna-Pignatti [7,9]. This may be due to the sex bias as more 
attention and care is given to male children in seeking health-
care delivery system, timely blood transfusion, or more chelation 
therapy use. The QOL score was better in Hindu population and 
it was statistically significant. The reason may be multifactorial 
such as family size and education of parents, whether children 
were school going or not and socioeconomic status.
Patients maintaining pre-transfusion Hb >7 g/dl had better 
total QOL score as observed in earlier studies also [2,7,10-12]. 
A number of symptoms such as fatigue, generalized weakness, 
decreased mental alertness, and decreased school performance 
may lead to impairment of health-related QOL (HRQOL). 
Thavorncharoensap et al. and Saha et al. found that severity 
of disease was an important predictor of QOL score [2,7]. In 
the present study, QOL score was worse in children who got 
transfusion for >5 years which could be due to more iron overload 
after more transfusions. The QOL was significantly higher in all 
domains of HRQOL score in children with higher ferritin levels. 
These results were in accordance to the study by Ismail et al. [13].
On multiple regression analysis, total QOL score was correlated 
with four independent variables including socioeconomic status, pre-
transfusion Hb level, iron chelation therapy, and duration of blood 
transfusion. The limitations of the study were that the approach of 
the support group, psychosocial counseling, and emotional support 
was not considered during the assessment in the study.
CONCLUSION
Iron chelation therapy, pre-transfusion Hb level above 7 g/dl, 
regular blood transfusions, family socioeconomic status, and 
late onset of blood transfusion are associated with better QOL. 
Therapy should widen beyond drugs with adequate physical 
rehabilitation and emotional support.
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